openPR Logo
Press release

Radiotherapy Market to Reach USD 11.80 Billion by 2030, Driven by Cancer Rise & Device Innovation

06-23-2025 09:30 AM CET | Health & Medicine

Press release from: Mordor Intelligence

Radiotherapy Market Size & Trends | Mordor Intelligence

Radiotherapy Market Size & Trends | Mordor Intelligence

Mordor Intelligence has published a new report on the Radiotherapy Market, offering a comprehensive analysis of trends, growth drivers, and future projections.

The global radiotherapy market critical to cancer care stood at approximately USD 8.40 billion in 2025. According to Mordor Intelligence, it is projected to expand to USD 11.80 billion in 2030, growing at a 7.5% CAGR. Radiotherapy employs carefully targeted radiation to eliminate cancer cells and reduce tumours, serving as either a primary treatment or an adjunct alongside surgery, chemotherapy, or immunotherapy. Its role is expanding worldwide, prompted by rising cancer incidence, ongoing technological upgrades, and greater awareness among patients and healthcare professionals. This release outlines the major forces shaping the market, the evolving segments, key players, and expectations through 2029.

Report Overview: https://www.mordorintelligence.com/industry-reports/global-radiotherapy-market-industry?utm_source=openpr

Key Trends

Rising Cancer Incidence

An increasing global cancer burden fuels demand for radiotherapy systems. As cancer cases surge, healthcare providers are integrating more devices to meet the treatment needs of early-stage and advanced cancers alike.

Device Innovation & Upgrades

Manufacturers are rapidly improving tools-with newer platforms like intensity-modulated radiotherapy (IMRT), image-guided radiotherapy (IGRT), and machine designs that enhance precision. These refinements support adoption by enabling more accurate dose targeting and reducing patient side effects.

Regional Growth Patterns

North America remains the largest market, supported by major device companies, high cancer incidence, and continual product launches

Asia-Pacific is the fastest-growing area, building capacity and investing heavily in infrastructure to support rising cancer rates.

Market Segmentation

By Product Category

Radiotherapy Equipment
Brachytherapy Equipment
Radiotherapy Software
Services & Maintenance

By Technology

Photon Beam Therapy
Proton Beam Therapy
Carbon Ion Therapy
Brachytherapy

By Therapy Type

External Beam Radiation Therapy (EBRT)
Proton-based EBRT

By Application

Breast Cancer
Lung Cancer

By End User

Hospitals

Cancer Treatment Centers & Outpatient Clinics

By Geography

North America
Europe
Asia-Pacific
Middle East & Africa
South America

Explore Our Full Library of Healthcare Industry Research Reports

https://www.mordorintelligence.com/market-analysis/healthcare?utm_source=openpr

Key Players

The market features established firms advancing both hardware and planning software:

GE Healthcare
Leveraging its deep footprint in diagnostic imaging, GE Healthcare is a top five player in radiotherapy equipment. It supports treatment centres through linac systems and complementary imaging solutions for radiotherapy planning and delivery.

Accuray Incorporated
Known for its CyberKnife and TomoTherapy systems, Accuray supplies advanced platforms that enable radiosurgery and image-guided radiotherapy. Its strength in precision systems makes it a key competitor in both hospital and specialized oncology settings.

Siemens Healthineers AG
With a broad medical technology portfolio, Siemens strengthened its radiotherapy position by acquiring Varian in 2021. Siemens now markets both linear accelerators and treatment planning software, making it one of the foremost suppliers

Elekta
A Swedish company offering a complete portfolio of linear accelerators (such as Versa HD and Unity MR‐Linac), brachytherapy units, and treatment planning software. Elekta is consistently ranked among the top five market leaders

For More Information Regarding Major Players visit https://www.mordorintelligence.com/industry-reports/global-radiotherapy-market-industry/companies?utm_source=openpr

Conclusion

The global radiotherapy market is projected to grow from USD 9.77 billion in 2023 to approximately USD 11.80 billion by 2030, at a 7.5% annual growth rate

This growth reflects two main dynamics:

A rising number of cancer patients worldwide.

Advancements in technology-especially in precision targeting and real-time imaging-that make treatments safer and more effective.

Although established markets in North America and Europe will continue driving revenue, the most dynamic expansion is expected in Asia-Pacific, where countries are ramping up capacity and access.

With healthcare systems increasingly embracing next-generation treatment planning tools and radiotherapy platforms, patient outcomes should improve, while the medical market for these technologies strengthens. The outlook is clear: as the global cancer burden grows, so does the imperative for advanced radiotherapy-helping clinicians deliver more precise and accessible treatment to patients worldwide.

Industry Related Reports

Intraoperative Radiation Therapy Market : The Intraoperative Radiation Therapy Market report segments the industry into By Method (Electron IORT, Intraoperative Brachytherapy, Other Methods), By Products and Services (Products, Services), By Application (Breast Cancer, Brain Tumor, Gastrointestinal Cancer, Head and Neck Cancer, Other Applications), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America).

Get More Insights: https://www.mordorintelligence.com/industry-reports/intraoperative-radiation-therapy-market?utm_source=openpr

Asia-Pacific Pancreatic Cancer Therapeutics & Diagnostics Market: The market is segmented by Cancer Type, Treatment (Surgery, Chemotherapy, Radiation Therapy, Targeted Therapy), Diagnostics, and Geography.

Get More Insights: https://www.mordorintelligence.com/industry-reports/asia-pacific-pancreatic-cancer-therapeutics-diagnostics-market?utm_source=openpr

Absorbable Tissue Spacer Market: The Absorbable Tissue Spacer Industry Report is segmented by Product Type (Hydrogel-Based Spacers and Biodegradable Balloon Spacers), Application (Radiotherapy and Infection Management), End User (Hospitals, Ambulatory Surgical Centers, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The value is provided in USD for the above segments.

Get More Insights: https://www.mordorintelligence.com/industry-reports/absorbable-tissue-spacer-market?utm_source=openpr

About Mordor Intelligence:

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

For any inquiries or to access the full report, please contact:

media@mordorintelligence.com
https://www.mordorintelligence.com/

Mordor Intelligence, 11th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli, Hyderabad, Telangana - 500032, India

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

For any inquiries or to access the full report, please contact:

media@mordorintelligence.com
https://www.mordorintelligence.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Radiotherapy Market to Reach USD 11.80 Billion by 2030, Driven by Cancer Rise & Device Innovation here

News-ID: 4076703 • Views:

More Releases from Mordor Intelligence

Biosimilars Market Projected to Reach USD 97.32 Billion by 2030, Driven by Expanding Therapeutic Applications and Strategic Collaborations
Biosimilars Market Projected to Reach USD 97.32 Billion by 2030, Driven by Expan …
Mordor Intelligence has published a new report on the Biosimilars Market, offering a comprehensive analysis of trends, growth drivers, and future projections. The global biosimilars market is experiencing significant growth, with projections indicating an increase from USD 41.97 billion in 2025 to USD 97.32 billion by 2030, reflecting a compound annual growth rate (CAGR) of 18.32%. This expansion is attributed to the broadening of biosimilars' therapeutic applications, strategic partnerships, and
Polycystic Ovarian Syndrome Treatment Market to Reach USD 3.5 Billion by 2030, Driven by Drug Therapies and Rising Awareness in Asia-Pacific
Polycystic Ovarian Syndrome Treatment Market to Reach USD 3.5 Billion by 2030, D …
Mordor Intelligence has published a new report on the Polycystic Ovarian Syndrome Treatment Market, offering a comprehensive analysis of trends, growth drivers, and future projections. The global polycystic ovarian syndrome (PCOS) Treatment Market to expand at a compound annual growth rate (CAGR) of 5.2% between 2025 and 2030, with North America remaining the largest market and Asia‐Pacific showing the fastest growth. Polycystic Ovarian Syndrome (PCOS) affects 6-12% of women
US Natural Gas Market to Grow at Over 5% CAGR by 2030 Backed by Power Generation and LNG Export Growth
US Natural Gas Market to Grow at Over 5% CAGR by 2030 Backed by Power Generation …
Mordor Intelligence has published a new report on the US Natural Gas Market, offering a comprehensive analysis of trends, growth drivers, and future projections. Introduction The US natural gas market is estimated to grow at a compound annual growth rate (CAGR) of more than 5% during the forecast period, 2025 to 2030. This growth is underpinned by robust demand from the electric power sector, rising liquefied natural gas (LNG)
U.S. Ceramic Tiles Market to Reach USD 6.24 Billion by 2030, Driven by Innovation and Sustainable Design Trends
U.S. Ceramic Tiles Market to Reach USD 6.24 Billion by 2030, Driven by Innovatio …
Mordor Intelligence has published a new report on the US Ceramic Tiles Market, offering a comprehensive analysis of trends, growth drivers, and future projections. US Ceramic Tiles Market Overview The U.S. ceramic tiles market is projected to grow from USD 4.94 billion in 2025 to USD 6.24 billion by 2030, reflecting a compound annual growth rate (CAGR) of 4.76%. This growth is fueled by a combination of factors, including increased construction

All 5 Releases


More Releases for Therapy

Global Corticosteroids Therapy Market | Global Corticosteroids Therapy Industry …
The corticosteroids therapy market comprises of sales of artificial corticosteroid drugs utilized to treat a wide variety of syndromes, including asthma, arthritis, skin conditions, and autoimmune diseases and lowers inflammation in the body. Corticosteroids and their biologically active synthetic derivatives vary in their metabolic (glucocorticoid) and electrolyte-regulating (mineralocorticoid) activities. These agents are active at physiological doses for additional therapy when endogenous manufacture is impaired. The market involves of revenue created
Stem Cell Therapy Revolutionizing Conventional Therapy Market
"Global Cell Therapy Market, Clinical Trials, Therapy Price & Opportunity Insight 2026" Report Highlights: • Global Cell Therapy Market Opportunity: More Than US$ 35 Billion by 2026 • Cell Therapy Clinical Trial Insight by Indication, Company & Country • Global Cell Therapy Clinical Pipeline: 767 Cell Therapies • Globally Marketed Cell Therapies: 25 Cell Therapies • Maximum Number of Marketed Cell Therapies In USA: 15 Therapies • Price & Product Insight By Region/Country • Regional Analysis of the Cell Therapy Market Download
Physical Therapy Supplies Market is classified into physical therapy services, o …
As per The Institute of Physical Therapy and Applied Science, physical therapy is a holistic approach based on the manual treatment of soft tissues, i.e. muscles, tendons, ligaments and fascia. Hence, physical therapy differs greatly from physiotherapy as it does not specially treat the spine. The main equipment used for physical therapy include ramps, exercise balls, resistance exercise bands, Nordic Track, treatment tables, ultrasound, Isokinetic devices, electrical muscle stimulation equipment,
Gene Therapy Market, by Gene Therapy Type Germline Gene Therapy and Somatic Gene …
Genes are composed of deoxyribonucleic acid (DNA), which contains essential information for producing proteins that are crucial for the optimal functioning of the body. Genetic disorder is the result of gene mutations in which proteins are made incorrectly. Gene therapy is intended to introduce healthy gene into damaged cells to counteract for abnormal genes or to make a protein of interest. Mutated gene causes missing of the important protein, with
Global Biologic Therapy Market up to 2023 | Staggering Double Digit CAGR By Ther …
Market Research Future published a research report on Global Biologic Therapy Market and predicts that Global General Surgical Devices Market is expected to grow at a healthy CAGR of 6.1% during the forecasted period and report include market Analysis, Size, Share, Recent Trends and forecast till 2023. The Global Biologic Therapy Market is majorly driven by the increasing rate of patient population, growing prevalence of several cancers, and the increasing demand
Global Biologic Therapy Market Ready to Set Superior Growth till 2023 with Major …
The Global Biologic Therapy Market is majorly driven by the increasing rate of patient population, growing prevalence of several cancers, and the increasing demand for biological and targeted drug therapies. Additionally, advancement in technologies for the treatment of chronic diseases and heavy research and development in the biologic therapy industry are likely to enhance the Global Biologic Therapy Market. Factors that are likely to hamper the growth of the market